fenofibrate has been researched along with leptin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, FM; Dutta-Roy, AK; Gordon, MJ; Hoggard, N | 1 |
| Bartek, J; Růzicka, V; Stejskal, D | 1 |
| An, YJ; Choi, SS; Garber, AJ; Hong, SH; Hwang, TH; Kang, DY; Kim, DK; Kim, MC; Lee, HJ; Park, MK; Seo, SY | 1 |
| Bartolini, G; Erickson, KL; Kelley, DS; Mackey, BE; Simon, VA; Warren, JM | 1 |
| Alvarez Fidalgo, P; Codoceo, R; Díez, JJ; Iglesias, P | 1 |
| Choi, JH; Han, M; Jeong, S; Kim, BH; Kim, J; Kim, M; Lee, H; Nam, KH; Nicol, CJ; Oh, GT; Yoon, M | 1 |
| Fatani, S; Naderali, EK; Williams, G | 1 |
| Fatani, S; Naderali, EK | 1 |
| Azhar, S; Bisgaier, CL; Jahagirdar, R; Sharma, S; Srivastava, RA | 1 |
| Fatani, S; Hunter, L; Naderali, EK; Telles, M | 1 |
| Jeong, S; Yoon, M | 1 |
| Bartlova, M; Dostalova, I; Haluzik, M; Haluzikova, D; Humenanska, V; Kasalicky, M; Lacinova, Z; Matoulek, M; Michalsky, D; Mraz, M | 1 |
| Arai, T; Chiba, H; Kim, HJ; Matsumoto, A | 1 |
| Inazu, A; Ito, N; Kawashiri, MA; Kobayashi, J; Mabuchi, H; Noguchi, T; Nohara, A; Oka, R; Sugihara, M; Tada, H; Takata, M; Yagi, K; Yamaaki, N; Yamagishi, M | 1 |
| Buldak, L; Dulawa-Buldak, A; Labuzek, K; Okopien, B | 1 |
| Arnould, T; Geeraert, B; Holvoet, P; Hulsmans, M; Tsatsanis, C | 1 |
| Botion, LM; Delpuerto, HL; Ferreira, AV; Mario, EG; Martins, AS; Menezes-Garcia, Z | 1 |
| Aguila, MB; Bringhenti, I; Mandarim-de-Lacerda, CA; Penna-de-Carvalho, A; Rachid, TL; Souza-Mello, V | 1 |
| Abd El-Haleim, EA; Bahgat, AK; Saleh, S | 1 |
3 trial(s) available for fenofibrate and leptin
| Article | Year |
|---|---|
[Serum leptin, early atherosclerosis and hypolipidemia (a new, previously undescribed effect of pravastatin, a hypolipemic agent)].
Topics: Adipose Tissue; Age of Onset; Arteriosclerosis; Body Mass Index; Female; Fenofibrate; Humans; Hypolipidemic Agents; Insulin; Leptin; Male; Middle Aged; Pravastatin; Proteins; Simvastatin | 1998 |
Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: results from a crossover study
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adipokines; Adiponectin; Adult; Aged; Bezafibrate; Body Mass Index; Cholesterol; Cholesterol, HDL; Cross-Over Studies; Deoxyguanosine; Diabetes Mellitus, Type 2; Female; Fenofibrate; Glucose Tolerance Test; Humans; Leptin; Male; Middle Aged; Peroxisome Proliferator-Activated Receptors; Proprotein Convertase 9; Proprotein Convertases; Serine Endopeptidases; Time Factors; Triglycerides | 2011 |
Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose.
Topics: Adipokines; Adiponectin; Adult; Aged; Analysis of Variance; Atorvastatin; Biomarkers; Blood Glucose; Cytokines; Drug Therapy, Combination; Female; Fenofibrate; Glucose Metabolism Disorders; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Interleukin-6; Leptin; Lipids; Male; Middle Aged; Poland; Pyrroles; Resistin; Risk Reduction Behavior; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |
16 other study(ies) available for fenofibrate and leptin
| Article | Year |
|---|---|
Interaction of free fatty acids with human leptin.
Topics: Carrier Proteins; Dansyl Compounds; Dextrans; Electrophoresis, Polyacrylamide Gel; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fatty Acids; Fluorescent Dyes; Humans; Isoelectric Point; Leptin; Liver; Myelin P2 Protein; Myocardium; Neoplasm Proteins; Oleic Acid; Protein Binding; Protein Conformation; Proteins; Recombinant Proteins; Tumor Suppressor Proteins | 1998 |
Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats.
Topics: Abdomen; Adipose Tissue; Animals; Body Weight; Carnitine O-Palmitoyltransferase; CD36 Antigens; Diabetes Mellitus, Type 2; Eating; Fenofibrate; Hypolipidemic Agents; Insulin; Leptin; Lipids; Liver; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Muscle, Skeletal; Organic Anion Transporters; Rats; Rats, Inbred OLETF; Receptors, Cytoplasmic and Nuclear; Statistics as Topic; Transcription Factors | 2002 |
Trans-10,cis-12 CLA increases liver and decreases adipose tissue lipids in mice: possible roles of specific lipid metabolism genes.
Topics: Acyl-CoA Oxidase; Adiponectin; Adipose Tissue; Animals; Apolipoprotein A-I; Apolipoprotein C-III; Apolipoproteins C; Blotting, Northern; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cytochrome P-450 Enzyme System; Female; Fenofibrate; Gene Expression Regulation; Intercellular Signaling Peptides and Proteins; Ion Channels; Isomerism; Leptin; Linoleic Acids, Conjugated; Lipids; Lipoprotein Lipase; Liver; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mitochondrial Proteins; Muscles; Myocardium; Organ Size; Oxidoreductases; Proteins; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Triglycerides; Uncoupling Protein 2 | 2003 |
Lipoatrophic diabetes in an elderly woman: clinical course and serum adipocytokine concentrations.
Topics: Adiponectin; Aged; Blood Glucose; Cytokines; Diabetes Mellitus, Lipoatrophic; Diabetes Mellitus, Type 2; Female; Fenofibrate; Hormones, Ectopic; Humans; Insulin; Intercellular Signaling Peptides and Proteins; Leptin; Metformin; Resistin; Tumor Necrosis Factor-alpha; Weight Loss | 2004 |
Effects of fenofibrate on high-fat diet-induced body weight gain and adiposity in female C57BL/6J mice.
Topics: Adipose Tissue; Animals; Body Composition; Body Weight; Dietary Fats; Eating; Fatty Acids; Female; Fenofibrate; Gene Expression Regulation; Hypolipidemic Agents; Leptin; Liver; Mice; Mice, Inbred C57BL; Ovariectomy; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Transcription Factors; Weight Gain | 2004 |
Fenofibrate lowers adiposity and corrects metabolic abnormalities, but only partially restores endothelial function in dietary obese rats.
Topics: Animals; Blood Glucose; Diet; Endothelial Cells; Fatty Acids, Nonesterified; Fenofibrate; Hypolipidemic Agents; Insulin Resistance; Leptin; Male; Obesity; Rats; Rats, Wistar; Triglycerides; Vasodilation | 2004 |
The effects of fenofibrate on metabolic and vascular changes induced by chocolate-supplemented diet in the rat.
Topics: Animals; Body Weight; Cacao; Carbachol; Dietary Supplements; Dose-Response Relationship, Drug; Endothelium, Vascular; Energy Intake; Fatty Acids, Nonesterified; Fenofibrate; Hematocrit; Hypolipidemic Agents; In Vitro Techniques; Leptin; Male; Mesenteric Arteries; Myocardium; Nitroprusside; Norepinephrine; Potassium Chloride; Random Allocation; Rats; Rats, Wistar; Triglycerides; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2005 |
Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
Topics: Adiposity; Animals; Aorta; Coronary Artery Disease; Diet, Atherogenic; Energy Metabolism; Fenofibrate; Gluconeogenesis; Hypercholesterolemia; Hypertriglyceridemia; Insulin; Insulin Resistance; Leptin; Ligands; Lipid Metabolism; Lipids; Lipogenesis; Liver; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; PPAR alpha; Receptors, LDL; Triglycerides; Weight Gain | 2006 |
The effects of physiological and pharmacological weight loss on adiponectin and leptin mRNA levels in the rat epididymal adipose tissue.
Topics: Adiponectin; Adipose Tissue; Animals; Epididymis; Fatty Acids, Nonesterified; Fenofibrate; Gene Expression Regulation; Hypolipidemic Agents; Leptin; Male; Obesity; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Triglycerides; Weight Loss | 2008 |
Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice.
Topics: 3T3 Cells; Adipocytes; Animals; Blood Glucose; Body Weight; Cell Enlargement; Dietary Fats; Fenofibrate; Gene Expression Regulation; Glucose Tolerance Test; Hypolipidemic Agents; Insulin; Insulin Resistance; Leptin; Lipids; Mice; Mice, Inbred C57BL; Mice, Obese; PPAR alpha; Tumor Necrosis Factor-alpha | 2009 |
Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.
Topics: Adiponectin; Adult; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fenofibrate; Fibroblast Growth Factors; Gene Expression; Humans; Leptin; Liver; Middle Aged; Obesity | 2009 |
Anti-obesity effect of fish oil and fish oil-fenofibrate combination in female KK mice.
Topics: Adiponectin; Animals; Anti-Obesity Agents; Base Sequence; Blood Glucose; DNA Primers; Female; Fenofibrate; Fish Oils; Insulin; Leptin; Mice; Obesity; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression.
Topics: Adipocytes; Adiponectin; Animals; Chemokine CCL2; Diet, High-Fat; Fenofibrate; Inflammation; Insulin; Insulin Resistance; Interleukin-1 Receptor-Associated Kinases; Leptin; Macrophages; Mice; Mice, Inbred C57BL; Obesity; Peroxisome Proliferator-Activated Receptors; Plaque, Atherosclerotic; PPAR alpha; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2013 |
Increased expression of oxidative enzymes in adipose tissue following PPARα-activation.
Topics: Acyl-CoA Oxidase; Adipose Tissue; Animals; Blood Glucose; Carnitine O-Palmitoyltransferase; Fatty Acids, Nonesterified; Fenofibrate; Glucose Tolerance Test; Insulin; Leptin; Male; Oxidation-Reduction; PPAR gamma; Rats; Rats, Wistar; RNA, Messenger | 2014 |
Fenofibrate (PPARalpha agonist) induces beige cell formation in subcutaneous white adipose tissue from diet-induced male obese mice.
Topics: Animals; Anti-Obesity Agents; Carbohydrate Metabolism; Cell Size; Cell Transdifferentiation; Diet, High-Fat; Fenofibrate; Gene Expression; Ion Channels; Leptin; Male; Mice, Inbred C57BL; Mitochondrial Proteins; Obesity; PPAR alpha; Subcutaneous Fat; Uncoupling Protein 1 | 2015 |
Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
Topics: Adiponectin; Adipose Tissue; Animals; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Fenofibrate; Fructose; Gene Expression Regulation; Glutathione; Homeostasis; Insulin; Leptin; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Pioglitazone; PPAR alpha; PPAR gamma; Rats; Rats, Wistar; Thiazolidinediones; Triglycerides; Tumor Necrosis Factor-alpha | 2016 |